Literature DB >> 28941549

The Corticostriatal Adenosine A2A Receptor Controls Maintenance and Retrieval of Spatial Working Memory.

Zhihui Li1, Xingjun Chen1, Tao Wang2, Ying Gao1, Fei Li1, Long Chen1, Jin Xue1, Yan He1, Yan Li1, Wei Guo1, Wu Zheng1, Liping Zhang1, Fenfen Ye1, Xiangpeng Ren1, Yue Feng3, Piu Chan3, Jiang-Fan Chen4.   

Abstract

BACKGROUND: Working memory (WM) taps into multiple executive processes including encoding, maintenance, and retrieval of information, but the molecular and circuit modulation of these WM processes remains undefined due to the lack of methods to control G protein-coupled receptor signaling with temporal resolution of seconds.
METHODS: By coupling optogenetic control of the adenosine A2A receptor (A2AR) signaling, the Cre-loxP-mediated focal A2AR knockdown with a delayed non-match-to-place (DNMTP) task, we investigated the effect of optogenetic activation and focal knockdown of A2ARs in the dorsomedial striatum (n = 8 to 14 per group) and medial prefrontal cortex (n = 16 to 22 per group) on distinct executive processes of spatial WM. We also evaluated the therapeutic effect of the A2AR antagonist KW6002 on delayed match-to-sample/place tasks in 6 normal and 6 MPTP-treated cynomolgus monkeys.
RESULTS: Optogenetic activation of striatopallidal A2ARs in the dorsomedial striatum selectively at the delay and choice (not sample) phases impaired DNMTP performance. Optogenetic activation of A2ARs in the medial prefrontal cortex selectively at the delay (not sample or choice) phase improved DNMTP performance. The corticostriatal A2AR control of spatial WM was specific for a novel but not well-trained DNMTP task. Focal dorsomedial striatum A2AR knockdown or KW6002 improved DNMTP performance in mice. Last, KW6002 improved spatial WM in delayed match-to-sample and delayed match-to-place tasks of normal and dopamine-depleted cynomolgus monkeys.
CONCLUSIONS: The A2ARs in striatopallidal and medial prefrontal cortex neurons exert distinctive control of WM maintenance and retrieval to achieve cognitive stability and flexibility. The procognitive effect of KW6002 in nonhuman primates provides the preclinical data to translate A2AR antagonists for improving cognitive impairments in Parkinson's disease.
Copyright © 2017 Society of Biological Psychiatry. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Adenosine A(2A) receptor; OptoA(2A)R; Parkinson’s disease; Prefrontal cortex; Spatial working memory; Striatum

Mesh:

Substances:

Year:  2017        PMID: 28941549     DOI: 10.1016/j.biopsych.2017.07.017

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  10 in total

1.  Adenosine A2A receptor blockade prevents cisplatin-induced impairments in neurogenesis and cognitive function.

Authors:  Alfredo Oliveros; Ki Hyun Yoo; Mohammad Abdur Rashid; Ana Corujo-Ramirez; Benjamin Hur; Jaeyun Sung; Yuanhang Liu; John R Hawse; Doo-Sup Choi; Detlev Boison; Mi-Hyeon Jang
Journal:  Proc Natl Acad Sci U S A       Date:  2022-07-07       Impact factor: 12.779

2.  Entrainment of Astrocytic and Neuronal Ca2+ Population Dynamics During Information Processing of Working Memory in Mice.

Authors:  Zhu Lin; Feng You; Ting Li; Yijia Feng; Xinyue Zhao; Jingjing Yang; Zhimo Yao; Ying Gao; Jiang-Fan Chen
Journal:  Neurosci Bull       Date:  2021-10-26       Impact factor: 5.271

Review 3.  Research progress on adenosine in central nervous system diseases.

Authors:  Ying-Jiao Liu; Jiao Chen; Xun Li; Xin Zhou; Yao-Mei Hu; Shi-Feng Chu; Ye Peng; Nai-Hong Chen
Journal:  CNS Neurosci Ther       Date:  2019-07-23       Impact factor: 5.243

4.  Using rat operant delayed match-to-sample task to identify neural substrates recruited with increased working memory load.

Authors:  Christina Gobin; Lizhen Wu; Marek Schwendt
Journal:  Learn Mem       Date:  2020-10-15       Impact factor: 2.460

Review 5.  The Pharmacological Potential of Adenosine A2A Receptor Antagonists for Treating Parkinson's Disease.

Authors:  Akihisa Mori; Jiang-Fan Chen; Shinichi Uchida; Cecile Durlach; Shelby M King; Peter Jenner
Journal:  Molecules       Date:  2022-04-06       Impact factor: 4.411

6.  Genetic tagging of the adenosine A2A receptor reveals its heterogeneous expression in brain regions.

Authors:  Muran Wang; Zewen Li; Yue Song; Qiuqin Sun; Lu Deng; Zhiqing Lin; Yang Zeng; Chunhong Qiu; Jingjing Lin; Hui Guo; Jiangfan Chen; Wei Guo
Journal:  Front Neuroanat       Date:  2022-08-18       Impact factor: 3.543

7.  Cognitive changes mediated by adenosine receptor blockade in a resveratrol-treated atherosclerosis-prone lupus mouse model.

Authors:  Lora J Kasselman; Heather A Renna; Iryna Voloshyna; Aaron Pinkhasov; Irving H Gomolin; Isaac Teboul; Joshua De Leon; Steven E Carsons; Allison B Reiss
Journal:  J Tradit Complement Med       Date:  2022-02-01

8.  Pharmacological Blockade of Adenosine A2A but Not A1 Receptors Enhances Goal-Directed Valuation in Satiety-Based Instrumental Behavior.

Authors:  Yan Li; Xinran Pan; Yan He; Yang Ruan; Linshan Huang; Yuling Zhou; Zhidong Hou; Chaoxiang He; Zhe Wang; Xiong Zhang; Jiang-Fan Chen
Journal:  Front Pharmacol       Date:  2018-04-24       Impact factor: 5.810

9.  Adenosine A2A Receptors in Bone Marrow-Derived Cells Attenuate Cognitive Impairment in Mice After Chronic Hypoperfusion White Matter Injury.

Authors:  Hong Ran; Jichao Yuan; Jialu Huang; Jie Wang; Kangning Chen; Zhenhua Zhou
Journal:  Transl Stroke Res       Date:  2020-05-11       Impact factor: 6.800

Review 10.  Optical control of purinergic signaling.

Authors:  Tao Wang; Henning Ulrich; Alexey Semyanov; Peter Illes; Yong Tang
Journal:  Purinergic Signal       Date:  2021-06-22       Impact factor: 3.765

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.